This has led to research into other therapeutic avenues including the use of novel therapies targeting small molecules (chemokines), the most studied one being CXCR4, which is implicated in tumour cell migration and the formation of metastasis in HNSCC [33]. This evidence concerns the gene CXCR4 and neoplasm.